For decades, many women used talcum powder for personal hygiene, including in the genital area. Whether that use raises the risk of ovarian cancer is one of the most contested questions in product-liability law. This page summarizes what the major cancer bodies say and where the litigation stands. It is educational reference material, not medical or legal advice.
What is alleged
Many lawsuits allege that women who applied talcum powder to the genital area developed ovarian cancer. The federal cases were described by the Judicial Panel on Multidistrict Litigation as actions by plaintiffs who allege that they or their decedents “developed ovarian or uterine cancer following perineal application” of talcum powder products. The manufacturers deny that their products cause cancer.
Two separate theories run through these cases: that talc itself can cause ovarian cancer, and that some talc was allegedly contaminated with asbestos, a known carcinogen.
What the cancer agencies say
- International Agency for Research on Cancer (IARC), 2024. IARC classified talc as “probably carcinogenic to humans” (Group 2A), based on limited evidence in humans for ovarian cancer, sufficient evidence in experimental animals, and strong mechanistic evidence. Talc containing asbestos remains in IARC’s highest category, “carcinogenic to humans,” as part of asbestos.
- American Cancer Society. The ACS describes the human studies as mixed. Case-control studies have often found a small increase in risk but can be biased by people’s memory of past use; prospective cohort studies have generally not found a significant increase overall. The ACS notes that if there is an increased risk for an individual woman, it is likely to be small, and that it is hard to separate the effect of talc itself from possible past asbestos contamination.
Where the litigation stands (November 2026)
- Federal cases. In October 2016 the Judicial Panel on Multidistrict Litigation centralized the federal talc cases against Johnson & Johnson in the U.S. District Court for the District of New Jersey as In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, MDL No. 2738. Most of those cases involve ovarian cancer.
- Johnson & Johnson’s bankruptcy route. A plan by J&J’s subsidiary Red River Talc LLC to resolve talc claims through bankruptcy was denied by the bankruptcy court on March 31, 2025. J&J said it would return to the court system and litigate the claims, and it maintains that its talc products are safe.
Ovarian cancer and mesothelioma are different questions
Mesothelioma is the cancer most closely tied to asbestos, and claims that asbestos-contaminated talc caused mesothelioma rest on different evidence from the ovarian cancer cases. For that side of the talc story, see Is talcum powder asbestos? The talc lawsuits and the talc products and companies reference.
Sources: IARC press release No. 352, “IARC Monographs evaluate the carcinogenicity of talc and acrylonitrile” (July 5, 2024); American Cancer Society, “Talcum Powder and Cancer” (last revised August 1, 2024); Judicial Panel on Multidistrict Litigation, Transfer Order, MDL No. 2738 (October 4, 2016); Johnson & Johnson press release, March 31, 2025. This page is educational and does not constitute legal or medical advice.